Continental Advisors LLC Sells 5,000 Shares of Cardinal Health, Inc. $CAH

Key Points

• Continental Advisors LLC reduced its stake in Cardinal Health, Inc. by 27.5%, selling 5,000 shares and now holding 13,184 shares, which account for approximately 1.0% of its portfolio.
• Cardinal Health reported a quarterly earnings per share of $2.08, exceeding analyst expectations, and has set EPS guidance for FY 2026 at $9.300-9.500.
• The company declared a quarterly dividend of $0.5107, with an ex-dividend date of October 1st, resulting in an annualized dividend yield of 1.4%.

Continental Advisors LLC decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 27.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 13,184 shares of the company's stock after selling 5,000 shares during the period. Cardinal Health comprises approximately 1.0% of Continental Advisors LLC's holdings, making the stock its 28th largest position. Continental Advisors LLC's holdings in Cardinal Health were worth $1,816,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of the business. JPMorgan Chase & Co. grew its position in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock valued at $575,327,000 after acquiring an additional 1,193,983 shares during the period. Northern Trust Corp grew its position in shares of Cardinal Health by 3.5% during the 1st quarter. Northern Trust Corp now owns 3,143,003 shares of the company's stock valued at $433,012,000 after acquiring an additional 105,154 shares during the period. Wellington Management Group LLP grew its position in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock valued at $328,470,000 after acquiring an additional 2,249,241 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in shares of Cardinal Health by 4.3% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock valued at $274,599,000 after acquiring an additional 94,768 shares during the period. Finally, Price T Rowe Associates Inc. MD grew its position in shares of Cardinal Health by 3.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 1,654,036 shares of the company's stock valued at $227,877,000 after acquiring an additional 52,714 shares during the period. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Up 0.5%

Shares of CAH stock opened at $150.29 on Tuesday. The stock has a market cap of $35.89 billion, a P/E ratio of 23.30, a PEG ratio of 1.26 and a beta of 0.73. Cardinal Health, Inc. has a 52 week low of $106.54 and a 52 week high of $168.44. The company's fifty day simple moving average is $155.51 and its two-hundred day simple moving average is $147.27.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. The business had revenue of $60.16 billion for the quarter, compared to analysts' expectations of $60.91 billion. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business's quarterly revenue was up .5% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.84 EPS. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st will be paid a $0.5107 dividend. The ex-dividend date is Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.4%. Cardinal Health's payout ratio is presently 31.63%.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on CAH shares. Wells Fargo & Company reissued an "overweight" rating and set a $185.00 price objective (up previously from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Jefferies Financial Group set a $150.00 target price on shares of Cardinal Health in a research note on Tuesday, August 12th. Citigroup restated a "neutral" rating and set a $170.00 target price (up previously from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. UBS Group restated a "buy" rating on shares of Cardinal Health in a research note on Tuesday, August 12th. Finally, Robert W. Baird lifted their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the company an "outperform" rating in a research note on Wednesday, August 13th. Twelve equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Cardinal Health presently has a consensus rating of "Moderate Buy" and an average price target of $165.93.

Insiders Place Their Bets

In other Cardinal Health news, CEO Jason M. Hollar sold 35,901 shares of the business's stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the sale, the chief executive officer owned 200,000 shares in the company, valued at $30,008,000. The trade was a 15.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Michelle D. Greene sold 13,500 shares of the business's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares in the company, valued at approximately $2,228,728.32. The trade was a 47.41% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 271,676 shares of company stock worth $40,489,525. 0.09% of the stock is owned by corporate insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.